Thyseed Is Set to Support Southeast Asian Families with Safer Infant Feeding Solutions, Powered by Medical-Grade Technology
Since its inception, Thyseed has championed a commitment to safeguarding infants from their earliest interactions with feeding products in a move to transform infant feeding safety through profound consumer insights and groundbreaking collaborations with global material scientists. Each product embodies Thyseed's philosophy of Design From Love, establishing the brand as the trusted innovator in premium baby care worldwide.
Brand Commitment: Safety Built on Love
Thyseed incorporates its Design From Love philosophy into every part of the brand experience. This love is shown in its strong focus on safety, believing that "every touchpoint matters in early development." Thyseed goes beyond global safety standards, using a full safety system from raw materials to finished products. All raw materials are checked for safety, production areas meet medical-grade cleanliness standards, and finished products undergo over 40 strict tests by SGS and other trusted agencies to ensure they are free from harmful substances. This commitment also reflects a deep respect for infant development. Thyseed's designers carefully create each product to fit the specific needs of infants from 0-3 years old, considering things like swallowing patterns, grip development, and oral-motor development, while avoiding unnecessary features and supporting natural feeding instincts.
Global Partnerships Driving Material Innovation for Infant Health
To ensure the highest safety for products that come into direct contact with infants, Thyseed has teamed up with top material suppliers. In partnership with Germany's BASF, the company developed a special food-safe PPSU material for infants. This material stays strong even after repeated sterilization at 180°C, offers great impact resistance and clarity, and meets top safety standards like US FDA and EU EFSA certifications, preventing harmful substances from leaching out.
Thyseed also works with Germany's WACKER to create custom medical-grade liquid silicone for nipples. This material passes 3,000 elasticity tests to ensure it stays soft, feels like breastfeeding, has low impurities, and is certified by Switzerland's SGS for safer suckling. These collaborations go beyond simple sourcing, as they work together to create strict safety and material guidelines for infant products.
Complete Feeding System: Designed for Safe Growth from Day One
Rooted in uncompromising safety, Thyseed has engineered a comprehensive 0-3 year feeding system. The Thyseed Transition Baby Bottle series provides two material options, medical-grade PPSU and silicone. Each is improved with the breast-like nipple design that adapts to baby's feeding style. Full-range solutions, including bottles, training cups, utensils, and pacifiers, adhere to a product development approach grounded in high-performance materials and evidence-based design principles, delivering stage-appropriate safety.
Moving forward, Thyseed will continue to safeguard babies' first-contact safety worldwide through love-guided innovation with science-backed quality.
CONTACT: zhanghuilin@thyseed.com
View original content to download multimedia:https://www.prnewswire.com/news-releases/thyseed-is-set-to-support-southeast-asian-families-with-safer-infant-feeding-solutions-powered-by-medical-grade-technology-302522863.html
SOURCE Thyseed
Hashtags
Try Our AI Features
Explore what Daily8 AI can do for you:
Comments
No comments yet...
Related Articles
Yahoo
5 minutes ago
- Yahoo
August 2025's Asian Stock Picks For Estimated Value Opportunities
As global trade tensions and economic uncertainties weigh on markets, Asian indices have experienced mixed performances, with China's economy showing signs of slowing growth and Japan's market facing renewed pressure from international developments. In this environment, identifying undervalued stocks in Asia could present potential opportunities for investors seeking to capitalize on discrepancies between market price and intrinsic value. Top 10 Undervalued Stocks Based On Cash Flows In Asia Name Current Price Fair Value (Est) Discount (Est) Xiaocaiyuan International Holding (SEHK:999) HK$10.27 HK$20.32 49.5% Xi'an NovaStar Tech (SZSE:301589) CN¥157.17 CN¥311.32 49.5% Wuxi Zhenhua Auto PartsLtd (SHSE:605319) CN¥33.56 CN¥65.39 48.7% NEOWIZ (KOSDAQ:A095660) ₩26950.00 ₩52750.47 48.9% LigaChem Biosciences (KOSDAQ:A141080) ₩149100.00 ₩288985.41 48.4% Hibino (TSE:2469) ¥2440.00 ¥4729.93 48.4% Heartland Group Holdings (NZSE:HGH) NZ$0.80 NZ$1.58 49.5% GEM (SZSE:002340) CN¥6.53 CN¥12.93 49.5% cottaLTD (TSE:3359) ¥444.00 ¥871.79 49.1% Andes Technology (TWSE:6533) NT$277.50 NT$541.97 48.8% Click here to see the full list of 266 stocks from our Undervalued Asian Stocks Based On Cash Flows screener. We're going to check out a few of the best picks from our screener tool. LigaChem Biosciences Overview: LigaChem Biosciences Inc., a clinical stage biopharmaceutical company, focuses on discovering and developing medicines for unmet medical needs and has a market capitalization of approximately ₩5.41 trillion. Operations: The company's revenue is primarily derived from its Pharmaceutical Business segment, which generated approximately ₩20.86 billion, and its New Drug Research and Development segment, contributing around ₩125.56 billion. Estimated Discount To Fair Value: 48.4% LigaChem Biosciences is trading at ₩149,100, significantly below its estimated fair value of ₩288,985.41. Despite recent share price volatility and low forecasted return on equity (7.4%), the company has become profitable this year with earnings expected to grow 50.5% annually, outpacing the KR market's 22.2%. Recent developments include a completed share buyback and ongoing Phase 1 trials for LNCB74 targeting advanced solid tumors, highlighting potential growth avenues amid robust cash flow prospects. Upon reviewing our latest growth report, LigaChem Biosciences' projected financial performance appears quite optimistic. Click to explore a detailed breakdown of our findings in LigaChem Biosciences' balance sheet health report. Beijing Zhong Ke San Huan High-Tech Overview: Beijing Zhong Ke San Huan High-Tech Co., Ltd. operates in the high-tech sector, focusing on the production and development of advanced magnetic materials, with a market cap of CN¥16.90 billion. Operations: Beijing Zhong Ke San Huan High-Tech Co., Ltd. generates its revenue primarily from the production and development of advanced magnetic materials. Estimated Discount To Fair Value: 25.1% Beijing Zhong Ke San Huan High-Tech is currently trading at CNY 14.04, well below its estimated fair value of CNY 18.75. The company reported a turnaround with net income of CNY 43.99 million for the first half of 2025, compared to a loss last year, indicating improved financial health despite recent sales decline. Earnings are forecasted to grow significantly at 46.8% annually over the next three years, surpassing market averages and suggesting strong cash flow potential amidst low return on equity forecasts. The analysis detailed in our Beijing Zhong Ke San Huan High-Tech growth report hints at robust future financial performance. Delve into the full analysis health report here for a deeper understanding of Beijing Zhong Ke San Huan High-Tech. Silergy Overview: Silergy Corp. designs, manufactures, and sells integrated circuit products and related technical services in China and internationally, with a market cap of NT$129.60 billion. Operations: The company's revenue is primarily derived from its semiconductors segment, which generated NT$18.71 billion. Estimated Discount To Fair Value: 33% Silergy is trading at NT$335, significantly below its estimated fair value of NT$500.22, highlighting potential undervaluation based on cash flows. The company reported strong Q1 2025 results with net income rising to TWD 358.56 million from TWD 78.01 million a year ago, suggesting robust financial performance despite a low forecasted return on equity of 14.9% in three years. Recent board changes may influence strategic direction positively amidst expected significant earnings growth of 34.1% annually over the next three years. The growth report we've compiled suggests that Silergy's future prospects could be on the up. Unlock comprehensive insights into our analysis of Silergy stock in this financial health report. Next Steps Take a closer look at our Undervalued Asian Stocks Based On Cash Flows list of 266 companies by clicking here. Are any of these part of your asset mix? Tap into the analytical power of Simply Wall St's portfolio to get a 360-degree view on how they're shaping up. Maximize your investment potential with Simply Wall St, the comprehensive app that offers global market insights for free. Curious About Other Options? Explore high-performing small cap companies that haven't yet garnered significant analyst attention. Diversify your portfolio with solid dividend payers offering reliable income streams to weather potential market turbulence. Fuel your portfolio with companies showing strong growth potential, backed by optimistic outlooks both from analysts and management. This article by Simply Wall St is general in nature. We provide commentary based on historical data and analyst forecasts only using an unbiased methodology and our articles are not intended to be financial advice. It does not constitute a recommendation to buy or sell any stock, and does not take account of your objectives, or your financial situation. We aim to bring you long-term focused analysis driven by fundamental data. Note that our analysis may not factor in the latest price-sensitive company announcements or qualitative material. Simply Wall St has no position in any stocks mentioned. Companies discussed in this article include KOSDAQ:A141080 SZSE:000970 and TWSE:6415. This article was originally published by Simply Wall St. Have feedback on this article? Concerned about the content? with us directly. Alternatively, email editorial-team@ Sign in to access your portfolio
Yahoo
25 minutes ago
- Yahoo
The robot shop: everything a robot owner needs under one roof
A new 'one stop shop' for the robot industry is about to open in Beijing. The facility will provide services like spare parts and robot leasing. (AP video shot by: Olivia Zhang) Solve the daily Crossword
Yahoo
34 minutes ago
- Yahoo
Asian Dividend Stocks To Watch In August 2025
As global markets grapple with trade tensions and economic uncertainties, the Asian market remains a focal point for investors seeking stability and growth opportunities. In this environment, dividend stocks in Asia offer potential value as they provide consistent income streams, which can be particularly appealing amid fluctuating market conditions. Top 10 Dividend Stocks In Asia Name Dividend Yield Dividend Rating Wuliangye YibinLtd (SZSE:000858) 5.17% ★★★★★★ Soliton Systems K.K (TSE:3040) 3.79% ★★★★★★ NCD (TSE:4783) 4.00% ★★★★★★ Japan Excellent (TSE:8987) 4.04% ★★★★★★ HUAYU Automotive Systems (SHSE:600741) 4.47% ★★★★★★ Guangxi LiuYao Group (SHSE:603368) 4.11% ★★★★★★ GakkyushaLtd (TSE:9769) 4.20% ★★★★★★ DoshishaLtd (TSE:7483) 3.76% ★★★★★★ Daicel (TSE:4202) 4.56% ★★★★★★ CAC Holdings (TSE:4725) 4.79% ★★★★★★ Click here to see the full list of 1129 stocks from our Top Asian Dividend Stocks screener. Below we spotlight a couple of our favorites from our exclusive screener. Lenovo Group Simply Wall St Dividend Rating: ★★★★☆☆ Overview: Lenovo Group Limited is an investment holding company that develops, manufactures, and markets technology products and services with a market cap of approximately HK$138.31 billion. Operations: Lenovo Group's revenue is primarily derived from its Intelligent Devices Group ($50.53 billion), Solutions and Services Group ($8.46 billion), and Infrastructure Solutions Group ($14.52 billion). Dividend Yield: 3.5% Lenovo Group's dividend payments have been stable and growing over the past decade, supported by a low payout ratio of 44.4%, indicating they are well-covered by earnings. However, the dividend yield of 3.5% is lower than the top quartile in Hong Kong's market, and concerns exist about coverage from free cash flows. Recent strategic partnerships and product innovations may bolster future financial performance, potentially impacting its ability to sustain or increase dividends further. Click here and access our complete dividend analysis report to understand the dynamics of Lenovo Group. Insights from our recent valuation report point to the potential undervaluation of Lenovo Group shares in the market. Yangzijiang Shipbuilding (Holdings) Simply Wall St Dividend Rating: ★★★★★☆ Overview: Yangzijiang Shipbuilding (Holdings) Ltd. is an investment holding company involved in shipbuilding activities across Greater China and various international markets, with a market cap of SGD11.18 billion. Operations: Yangzijiang Shipbuilding (Holdings) Ltd. generates revenue primarily through its shipbuilding operations across multiple international markets, including Canada, Japan, Italy, Greece, Germany, Bulgaria, the United Kingdom, and Singapore. Dividend Yield: 4.2% Yangzijiang Shipbuilding's dividends have been stable and growing over the past decade, supported by a low payout ratio of 32.7%, indicating strong coverage by earnings. Despite a reliable dividend yield of 4.18%, it falls short compared to the top quartile in Singapore's market. Recent earnings growth, with net income rising to CNY 4.18 billion, highlights financial strength that may support continued dividend payments, though its yield remains less competitive among peers. Click here to discover the nuances of Yangzijiang Shipbuilding (Holdings) with our detailed analytical dividend report. The analysis detailed in our Yangzijiang Shipbuilding (Holdings) valuation report hints at an deflated share price compared to its estimated value. Test Research Simply Wall St Dividend Rating: ★★★★☆☆ Overview: Test Research, Inc. designs, assembles, manufactures, sells, and maintains automated inspection and testing equipment globally, with a market cap of NT$37.91 billion. Operations: Test Research, Inc.'s revenue is primarily derived from the design, assembly, manufacture, sale, and maintenance of automatic testing equipment, amounting to NT$6.79 billion. Dividend Yield: 3.1% Test Research's dividends have increased over the past decade, though they remain volatile and unreliable. The recent dividend increase to TWD 5 per share reflects improved earnings, with net income rising to TWD 1.1 billion for the first half of 2025. Despite a reasonable payout ratio of 60.3% and coverage by cash flows, its yield of 3.12% is below Taiwan's top quartile, suggesting limited competitiveness in dividend returns compared to leading payers in the market. Delve into the full analysis dividend report here for a deeper understanding of Test Research. Upon reviewing our latest valuation report, Test Research's share price might be too optimistic. Taking Advantage Delve into our full catalog of 1129 Top Asian Dividend Stocks here. Already own these companies? Bring clarity to your investment decisions by linking up your portfolio with Simply Wall St, where you can monitor all the vital signs of your stocks effortlessly. Invest smarter with the free Simply Wall St app providing detailed insights into every stock market around the globe. Ready For A Different Approach? Explore high-performing small cap companies that haven't yet garnered significant analyst attention. Fuel your portfolio with companies showing strong growth potential, backed by optimistic outlooks both from analysts and management. Find companies with promising cash flow potential yet trading below their fair value. This article by Simply Wall St is general in nature. We provide commentary based on historical data and analyst forecasts only using an unbiased methodology and our articles are not intended to be financial advice. It does not constitute a recommendation to buy or sell any stock, and does not take account of your objectives, or your financial situation. We aim to bring you long-term focused analysis driven by fundamental data. Note that our analysis may not factor in the latest price-sensitive company announcements or qualitative material. Simply Wall St has no position in any stocks mentioned. Companies discussed in this article include SEHK:992 SGX:BS6 and TWSE:3030. This article was originally published by Simply Wall St. Have feedback on this article? Concerned about the content? with us directly. Alternatively, email editorial-team@ Error while retrieving data Sign in to access your portfolio Error while retrieving data Error while retrieving data Error while retrieving data Error while retrieving data
